Alignment Healthcare, Inc.·4

Mar 17, 5:13 PM ET

KAO JOHN E 4

4 · Alignment Healthcare, Inc. · Filed Mar 17, 2026

Research Summary

AI-generated summary of this filing

Updated

Alignment Healthcare (ALHC) CEO John Kao Receives Award of 338,434 RSUs

What Happened John E. Kao, CEO of Alignment Healthcare (ALHC), received an award of 338,434 restricted stock units (RSUs) reported as an acquisition (A) on 2026-03-13. The grant is reported at $0.00 per unit (typical for RSU awards); total dollar value at grant is not stated in the filing. This is an equity award (not an open-market purchase or sale) and does not reflect an immediate cash outlay or disposition.

Key Details

  • Transaction date: 2026-03-13; Form 4 filed: 2026-03-17 (filed four days after the reported transaction; Form 4s are normally due within two business days, so this appears to be late).
  • Grant size and price: 338,434 RSUs reported at $0.00 per unit.
  • Shares owned after transaction: Not specified in the filing.
  • Footnotes:
    • F1: These are 338,434 restricted stock units, each convertible into one share, vesting approximately one-third on each of the first three anniversaries of the grant date, subject to continued service.
    • F2: References securities held by the JEK Trust (dated Feb 8, 2021), of which Mr. Kao is trustee (separate holdings disclosure).

Context Restricted stock units are equity awards that convert to shares only as they vest; they are not an immediate market purchase or sale. Because this is a grant, it’s a routine compensation event rather than a direct signal of buying or selling activity.

Insider Transaction Report

Form 4
Period: 2026-03-13
KAO JOHN E
DirectorChief Executive Officer
Transactions
  • Award

    Common Stock

    [F1]
    2026-03-13+338,4341,857,914 total
Holdings
  • Common Stock

    [F2]
    (indirect: See Footnote)
    2,472,641
Footnotes (2)
  • [F1]Represents 338,434 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.
  • [F2]Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.
Signature
/s/ Christopher J. Joyce, as Attorney-in-Fact, for John E. Kao|2026-03-17

Documents

1 file
  • 4
    wk-form4_1773782010.xmlPrimary

    FORM 4